Zoetis (ZTS) delivered earnings and revenue surprises of 10.19% and 6.30%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Let us take a look at what is in store for some of the drug/biotech stocks, which are scheduled to report on Aug 5.
Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zoetis (ZTS) will report earnings and revenues, and provide pipeline updates when it releases second-quarter 2021 results.
We take a look at a few pharma/biotech companies, which are poised to beat on earnings in the second quarter.
CORT vs. ZTS: Which Stock Is the Better Value Option?
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Dividend Challenger Highlights: Week Of July 18

11:34pm, Saturday, 17'th Jul 2021
Dividend Challenger Highlights: Week Of July 18
Futures on all three major U.S. stock exchanges were higher as investors assess better-than-expected news about retail sales.
The stock price of Zoetis, an animal health company, has seen a 10% rise over the last twenty-one trading days, while it is up 40% over the last year. ZTS stock has benefited from an increased animal
AMRX vs. ZTS: Which Stock Is the Better Value Option?
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #DrivenToCare--Zoetis is donating more than 11,000 doses of its experimental COVID-19 vaccine for animals to nearly 70 zoos across the U.S.
Stocks like PetIQ (PETQ), IDEXX Laboratories (IDXX), Phibro Animal Health (PAHC) and Zoetis (ZTS) offering animal health products and services make great picks for long term.
There are positive industry-wide tailwinds for Animal Health as a niche segment of the broader pharmaceuticals industry. Being a leader in Animal Health, ZTS is poised for long-term outperformance due
Zoetis stock has risen 2x from levels of $92 that it was at on March 23, 2020, when broader markets made a bottom, to levels of $184 now, while Merck's stock has underperformed and gained only 26% of
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE